Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 1,055 | 370 | 522 | 449 | 172 |
| Gross Profit | 1,055 | 370 | 522 | 449 | 172 |
| Operating Expenses | 10,286 | 11,797 | 11,465 | 13,208 | 7,644 |
| Operating Income | -9,231 | -11,427 | -10,944 | -12,759 | -7,472 |
| Other Income | 122 | 160 | 170 | 200 | 172 |
| Pre-tax Income | -9,109 | -11,267 | -10,773 | -12,559 | -7,300 |
| Income Tax | 413 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -9,522 | -11,267 | -11,598 | -12,559 | -7,300 |
| Net Income | $-9,522 | $-11,267 | $-11,598 | $-12,559 | $-7,300 |
| EPS Basic Total Ops | -0.46 | -0.54 | -0.59 | -0.62 | -0.36 |
| EPS Basic Continuous Ops | -0.46 | -0.54 | -0.57 | -0.62 | -0.36 |
| EPS Diluted Total Ops | -0.46 | -0.54 | -0.59 | -0.62 | -0.36 |
| EPS Diluted Continuous Ops | -0.46 | -0.54 | -0.57 | -0.62 | -0.36 |
| EBITDA(a) | $-9,026 | $-11,222 | $-10,740 | $-12,565 | $-7,277 |